Michael T Halpern1, Ya-Chen Tina Shih2, K Robin Yabroff3, Donatus U Ekwueme4, Cathy J Bradley5, Amy J Davidoff6, Lindsay M Sabik7, Joseph Lipscomb8. 1. Healthcare Delivery Research Program, National Cancer Institute, Bethesda, Maryland. 2. Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. 3. Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia. 4. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia. 5. Population Health Sciences, University of Colorado Cancer Center, University of Colorado, Aurora, Colorado. 6. Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, School of Medicine, Yale University, New Haven, Connecticut. 7. Department of Health Policy and Management, University of Pittsburgh, Pittsburgh, Pennsylvania. 8. Department of Health Policy and Management, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, Georgia.
Abstract
LAY SUMMARY: Cancer has substantial economic impacts for patients, their families and/or caregivers, employers, and the health care system. However, there is only limited understanding of how economic issues can affect access to cancer care services and the receipt of high-quality cancer care. Health economics research in cancer is particularly timely due to the large and increasing number of patients with cancer and cancer survivors, but there are many factors that may create barriers to performing cancer health economics research. This commentary has identified important topics and questions in cancer health economics research and will assist in the development of this critical field.
LAY SUMMARY: Cancer has substantial economic impacts for patients, their families and/or caregivers, employers, and the health care system. However, there is only limited understanding of how economic issues can affect access to cancer care services and the receipt of high-quality cancer care. Health economics research in cancer is particularly timely due to the large and increasing number of patients with cancer and cancer survivors, but there are many factors that may create barriers to performing cancer health economics research. This commentary has identified important topics and questions in cancer health economics research and will assist in the development of this critical field.
Authors: Angela B Mariotto; K Robin Yabroff; Yongwu Shao; Eric J Feuer; Martin L Brown Journal: J Natl Cancer Inst Date: 2011-01-12 Impact factor: 13.506
Authors: K Robin Yabroff; Elizabeth B Lamont; Angela Mariotto; Joan L Warren; Marie Topor; Angela Meekins; Martin L Brown Journal: J Natl Cancer Inst Date: 2008-04-29 Impact factor: 13.506
Authors: Angela B Mariotto; Lindsey Enewold; Jingxuan Zhao; Christopher A Zeruto; K Robin Yabroff Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-06-10 Impact factor: 4.090
Authors: Donatus U Ekwueme; Jingxuan Zhao; Sun Hee Rim; Janet S de Moor; Zhiyuan Zheng; Jaya S Khushalani; Xuesong Han; Erin E Kent; K Robin Yabroff Journal: MMWR Morb Mortal Wkly Rep Date: 2019-06-07 Impact factor: 17.586